₹9,119
-156.5 (-1.7%)![]()
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 9,309.5 | Bearish |
| 10-DMA | 9,395.8 | Bearish |
| 20-DMA | 9,274.17 | Bearish |
| 50-DMA | 8,735.67 | Bullish |
| 100-DMA | 8,079.95 | Bullish |
| 200-DMA | 7,550.33 | Bullish |
%
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 80,693 | 56,905 | 44,517 | 31,826 | 22,170 |
| Total Expenditure | 68,317 | 48,578 | 35,738 | 24,990 | 16,834 |
| Other Income | 614 | 251 | 182 | 125 | 81 |
| Operating Profit | 12,990 | 8,578 | 8,961 | 6,962 | 5,417 |
| Interest | 3,090 | 2,166 | 1,745 | 1,202 | 844 |
| Depreciation | 4,438 | 3,470 | 2,777 | 2,216 | 2,060 |
| Profit Before Tax | 5,343 | 2,696 | 4,447 | 3,548 | 2,517 |
| Consolidated Net Profit | 3,840 | 1,946 | 3,045 | 2,484 | 1,631 |
| Adjusted EPS | 161 | 82 | 144 | 118 | 77 |
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 119 | 119 | 106 | 106 | 106 |
| Total Reserves | 32,521 | 28,448 | 16,474 | 13,663 | 11,252 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 26,494 | 18,720 | 14,233 | 11,264 | 5,610 |
| Other Current Liabilities | 9,125 | 8,034 | 4,296 | 3,619 | 3,107 |
| Short Term Borrowings | 6,176 | 2,168 | 2,802 | 1,305 | 1,932 |
| Total Liabilities | 89,783 | 71,164 | 47,057 | 38,067 | 26,748 |
| Capital Work in Progress | 3,823 | 3,453 | 1,786 | 966 | 420 |
| Long Term Loans & Advances | 2,842 | 1,917 | 1,721 | 935 | 566 |
| Currents Investments | --- | --- | --- | --- | --- |
| Short Term Loans and Advances | 1,923 | 1,369 | 594 | 495 | 407 |
| Total Current Assets | 32,718 | 25,489 | 17,830 | 14,879 | 10,294 |
| Total Assets | 89,783 | 71,164 | 47,057 | 38,067 | 26,748 |
| Adjusted Book Value | 1,368 | 1,197 | 785 | 652 | 538 |
Investment Calculator
| Symbol | Change% |
|---|---|
| SUMICHEM | 502.3(14%) |
| ZENSARTECH | 516.1(10%) |
| AEGISVOPAK | 257.43(10%) |
| ECLERX | 1488.8(7%) |
| KAYNES | 3333.8(6%) |
Get Your Portfolio Reviewed

Stay Updated with Our Market Newsletters